Prostate Cancer - Results from #27640

Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy - Abstract June 22, 2011

Optimizing prostate cancer detection during biopsy by standardizing the amount of tissue examined per core - Abstract June 22, 2011

Recombinant origin of the retrovirus XMRV - Abstract June 22, 2011

Targeting 5α-reductase for prostate cancer prevention and treatment - Abstract June 22, 2011

Targeting the DNA double strand break repair machinery in prostate cancer - Abstract June 22, 2011

A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer - Abstract June 22, 2011

Serum prosaposin levels are increased in patients with advanced prostate cancer - Abstract June 22, 2011

Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer - Abstract June 22, 2011

Editor's Commentary - Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer June 22, 2011

Radical retropubic prostatectomy: A review of outcomes and side-effects - Abstract June 21, 2011

Hypofractionation for radiotherapy of prostate cancer using a low alfa/beta ratio--possible reasons for concerns? An example of five dimensional radiotherapy - Abstract June 21, 2011

Active surveillance in prostate cancer: The need to standardize - Abstract June 21, 2011

Old issues and new perspectives on prostate cancer hormonal therapy: The molecular substratum - Abstract June 21, 2011

Patterns of information behavior and prostate cancer knowledge among African-American men - Abstract June 21, 2011

Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients - Abstract June 21, 2011

Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics - Abstract June 21, 2011

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial June 21, 2011

A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008 - Abstract June 20, 2011

Pathology in prostate research: Optimizing the pathological data - Abstract June 20, 2011

Tumour markers in prostate cancer III: Biomarkers in urine - Abstract June 20, 2011

Page 1383 of 1436